# Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol

> **NCT01498861** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 16 (actual)

## Conditions studied

- Infection, Human Immunodeficiency Virus

## Interventions

- **DRUG:** Ortho-Cyclen
- **DRUG:** Dolutegravir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01498861
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-05-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01498861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01498861, "Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01498861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*